---
$id: https://graph.org.ai/products/commodity/51392207
$type: Product
source: UNSPSC
code: "51392207"
title: "Indanazoline"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Indanazoline

**UNSPSC Code**: 51392207
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H15N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0U38EHD86, chemically known as 1h-imidazol-2-amine, n-(2,3-dihydro-1h-inden-4-yl)-4,5-dihydro- but generally known as indanazoline, which bears US NIH Compound Identifier 65979. European Medicines Agency schedules Indanazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08166MIG. The term INDANAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). INDANAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Indanazoline under HS 29332990 and SITC 51573. As of Q4 2014, INDANAZOLINE remains the US FDA Preferred Term for this commodity. Indanazoline bears US NLM identifiers UMLS ID C0063449 and NCI Concept Code C65908. SMILES: C1CC2C(C(C1)NC3=NCCN3)CCC2.

